The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 756 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 1.13
Site | Ages <20 | Ages 20-34 | Ages 35-44 | Ages 45-54 | Ages 55-64 | Ages 65-74 | Ages 75-84 | Ages 85+ | All Ages | Number of Deaths |
---|---|---|---|---|---|---|---|---|---|---|
All Sites | 0.3 | 0.8 | 2.0 | 8.5 | 19.2 | 25.6 | 26.9 | 16.6 | 100.0% | 2,886,516 |
Oral Cavity & Pharynx: | 0.1 | 0.8 | 2.4 | 13.1 | 26.4 | 24.6 | 20.3 | 12.3 | 100.0% | 42,827 |
Lip | 0.3 | 0.6 | 1.5 | 7.4 | 14.7 | 18.3 | 27.1 | 30.1 | 100.0% | 339 |
Tongue | 0.1 | 1.1 | 3.1 | 13.6 | 27.3 | 24.7 | 19.3 | 10.8 | 100.0% | 10,617 |
Salivary gland | 0.1 | 1.0 | 2.5 | 9.0 | 17.0 | 21.8 | 26.3 | 22.3 | 100.0% | 4,197 |
Floor of mouth | 0.0 | 0.2 | 1.3 | 12.8 | 33.9 | 26.1 | 16.9 | 8.8 | 100.0% | 445 |
Gum & other oral cavity | 0.0 | 0.4 | 1.7 | 8.7 | 19.7 | 21.8 | 24.9 | 22.7 | 100.0% | 6,071 |
Nasopharynx | 0.8 | 3.3 | 5.8 | 18.3 | 28.0 | 21.2 | 16.0 | 6.7 | 100.0% | 3,302 |
Tonsil | 0.0 | 0.2 | 2.6 | 18.2 | 34.8 | 25.2 | 14.0 | 4.9 | 100.0% | 4,091 |
Oropharynx | 0.0 | 0.4 | 1.9 | 14.6 | 29.2 | 26.1 | 19.0 | 8.9 | 100.0% | 4,184 |
Hypopharynx | 0.0 | 0.2 | 1.1 | 14.0 | 28.3 | 28.3 | 20.1 | 8.0 | 100.0% | 1,605 |
Other oral cavity & pharynx | 0.0 | 0.1 | 1.3 | 12.3 | 28.4 | 27.9 | 20.5 | 9.5 | 100.0% | 7,976 |
Digestive System: | 0.0 | 0.5 | 2.0 | 9.3 | 21.2 | 24.6 | 25.6 | 16.7 | 100.0% | 722,266 |
Esophagus | 0.0 | 0.2 | 1.6 | 10.0 | 25.3 | 28.2 | 23.6 | 11.1 | 100.0% | 72,182 |
Stomach | 0.0 | 1.3 | 3.8 | 10.3 | 18.3 | 23.0 | 25.8 | 17.5 | 100.0% | 56,061 |
Small intestine | 0.0 | 0.9 | 2.6 | 8.9 | 20.2 | 25.2 | 26.0 | 16.2 | 100.0% | 6,232 |
Colon & Rectum: | 0.0 | 0.7 | 2.5 | 9.4 | 18.2 | 22.3 | 25.9 | 21.0 | 100.0% | 259,005 |
Colon & Rectum (Male) | 0.0 | 0.8 | 2.7 | 10.3 | 20.7 | 24.9 | 25.2 | 15.4 | 100.0% | 134,779 |
Colon & Rectum (Female) | 0.0 | 0.6 | 2.4 | 8.5 | 15.4 | 19.5 | 26.6 | 27.1 | 100.0% | 124,226 |
Anus, anal canal & anorectum | 0.0 | 0.6 | 5.1 | 18.5 | 25.7 | 21.4 | 17.4 | 11.2 | 100.0% | 4,283 |
Liver & intrahepatic bile duct | 0.2 | 0.5 | 1.5 | 11.4 | 30.0 | 24.2 | 21.8 | 10.3 | 100.0% | 108,268 |
Gallbladder | 0.0 | 0.2 | 1.4 | 6.9 | 18.0 | 27.5 | 28.4 | 17.6 | 100.0% | 10,516 |
Other biliary | 0.0 | 0.3 | 1.2 | 6.6 | 16.1 | 23.8 | 29.7 | 22.4 | 100.0% | 7,450 |
Pancreas | 0.0 | 0.2 | 1.2 | 7.5 | 20.1 | 27.0 | 27.8 | 16.3 | 100.0% | 187,653 |
Retroperitoneum | 0.3 | 1.3 | 2.5 | 9.8 | 21.1 | 25.2 | 25.8 | 14.0 | 100.0% | 1,007 |
Peritoneum, omentum & mesentery | 0.1 | 0.5 | 1.7 | 6.7 | 18.9 | 29.6 | 29.3 | 13.2 | 100.0% | 4,284 |
Other digestive system | 0.0 | 0.5 | 1.8 | 7.0 | 17.2 | 23.3 | 28.7 | 21.4 | 100.0% | 5,325 |
Respiratory System: | 0.0 | 0.1 | 0.8 | 7.4 | 20.1 | 31.0 | 28.8 | 11.8 | 100.0% | 809,848 |
Nose, nasal cavity & middle ear | 0.2 | 2.2 | 4.4 | 13.0 | 19.2 | 23.1 | 23.3 | 14.5 | 100.0% | 2,342 |
Larynx | 0.0 | 0.1 | 1.1 | 10.5 | 26.5 | 29.2 | 22.9 | 9.7 | 100.0% | 18,444 |
Lung & bronchus | 0.0 | 0.1 | 0.8 | 7.3 | 19.9 | 31.0 | 29.0 | 11.8 | 100.0% | 786,881 |
Lung & bronchus (Male) | 0.0 | 0.1 | 0.7 | 7.2 | 21.2 | 31.9 | 28.5 | 10.3 | 100.0% | 434,475 |
Lung & bronchus (Female) | 0.0 | 0.1 | 0.9 | 7.5 | 18.3 | 30.0 | 29.7 | 13.6 | 100.0% | 352,406 |
Pleura | 0.4 | 0.2 | 1.0 | 3.0 | 15.8 | 27.8 | 34.3 | 17.6 | 100.0% | 1,073 |
Trachea & other respiratory organs | 1.4 | 4.6 | 3.9 | 11.4 | 20.5 | 21.8 | 21.8 | 14.7 | 100.0% | 1,108 |
Bones & joints | 12.5 | 14.9 | 5.7 | 10.0 | 12.8 | 15.0 | 16.4 | 12.7 | 100.0% | 7,037 |
Soft tissue (including heart) | 3.7 | 6.1 | 6.2 | 13.1 | 19.6 | 20.1 | 19.4 | 11.8 | 100.0% | 22,146 |
Skin (excl. basal & squamous): | 0.1 | 1.7 | 3.9 | 10.4 | 19.0 | 21.7 | 24.8 | 18.3 | 100.0% | 61,883 |
Melanoma of the skin | 0.1 | 2.2 | 4.9 | 11.7 | 20.2 | 22.2 | 24.1 | 14.7 | 100.0% | 46,126 |
Other non-epithelial skin | 0.0 | 0.4 | 1.2 | 6.8 | 15.5 | 20.3 | 27.1 | 28.7 | 100.0% | 15,757 |
Breast (Female) | 0.0 | 0.9 | 5.0 | 14.0 | 22.0 | 21.4 | 20.1 | 16.6 | 100.0% | 204,613 |
Female Genital System: | 0.0 | 1.2 | 3.8 | 11.4 | 21.9 | 24.9 | 22.7 | 14.0 | 100.0% | 144,847 |
Cervix uteri | 0.0 | 5.2 | 13.5 | 23.9 | 23.7 | 16.1 | 11.3 | 6.3 | 100.0% | 20,231 |
Corpus uteri | 0.0 | 0.3 | 1.8 | 7.1 | 24.2 | 29.7 | 23.5 | 13.4 | 100.0% | 18,406 |
Uterus, NOS | 0.0 | 0.5 | 2.0 | 8.6 | 22.3 | 27.7 | 23.2 | 15.6 | 100.0% | 24,586 |
Ovary | 0.1 | 0.7 | 2.3 | 10.4 | 21.4 | 25.8 | 25.0 | 14.3 | 100.0% | 72,034 |
Vagina | 0.1 | 0.9 | 2.2 | 7.2 | 15.6 | 20.7 | 27.6 | 25.8 | 100.0% | 2,115 |
Vulva | 0.1 | 0.6 | 1.9 | 7.6 | 13.5 | 17.5 | 28.7 | 30.1 | 100.0% | 4,947 |
Other female genital system | 0.1 | 0.9 | 2.3 | 8.3 | 22.1 | 28.6 | 23.7 | 14.0 | 100.0% | 2,528 |
Male Genital System: | 0.0 | 0.5 | 0.4 | 2.0 | 9.1 | 20.6 | 34.6 | 32.9 | 100.0% | 142,995 |
Prostate | 0.0 | 0.0 | 0.1 | 1.6 | 9.0 | 20.8 | 35.1 | 33.5 | 100.0% | 139,543 |
Testis | 1.8 | 34.7 | 18.3 | 20.6 | 11.3 | 5.5 | 4.8 | 3.0 | 100.0% | 1,924 |
Penis | 0.1 | 1.0 | 3.8 | 10.7 | 21.0 | 25.2 | 23.1 | 15.2 | 100.0% | 1,274 |
Other male genital system | 0.4 | 0.8 | 2.4 | 9.1 | 13.0 | 22.4 | 29.1 | 22.8 | 100.0% | 254 |
Urinary System: | 0.2 | 0.3 | 1.1 | 6.2 | 16.1 | 23.6 | 29.6 | 23.0 | 100.0% | 146,090 |
Urinary bladder | 0.0 | 0.1 | 0.5 | 3.7 | 11.8 | 21.3 | 33.2 | 29.5 | 100.0% | 74,947 |
Kidney & renal pelvis | 0.3 | 0.5 | 1.7 | 9.1 | 21.2 | 26.2 | 25.4 | 15.5 | 100.0% | 67,197 |
Ureter | 0.1 | 0.3 | 0.4 | 3.1 | 10.0 | 24.2 | 35.9 | 26.1 | 100.0% | 1,871 |
Other urinary system | 0.0 | 0.1 | 1.3 | 5.6 | 12.9 | 22.5 | 32.0 | 25.5 | 100.0% | 2,075 |
Eye & Orbit | 2.0 | 1.9 | 4.1 | 10.1 | 20.5 | 22.7 | 22.8 | 15.8 | 100.0% | 1,439 |
Brain & Nervous System: | 3.7 | 3.6 | 5.5 | 13.5 | 23.9 | 23.9 | 18.5 | 7.5 | 100.0% | 73,450 |
Endocrine System: | 6.1 | 2.4 | 3.6 | 9.5 | 18.0 | 23.1 | 22.7 | 14.5 | 100.0% | 13,403 |
Thyroid | 0.1 | 0.9 | 1.9 | 7.8 | 17.8 | 25.2 | 27.5 | 18.8 | 100.0% | 8,680 |
Other endocrine & thymus | 17.1 | 5.2 | 6.8 | 12.7 | 18.5 | 19.2 | 13.8 | 6.6 | 100.0% | 4,723 |
Lymphoma: | 0.4 | 1.9 | 2.4 | 6.3 | 14.4 | 22.6 | 30.9 | 21.2 | 100.0% | 107,370 |
Hodgkin lymphoma | 1.3 | 11.8 | 9.2 | 10.9 | 15.2 | 19.0 | 21.3 | 11.3 | 100.0% | 5,869 |
Non-Hodgkin lymphoma | 0.3 | 1.3 | 2.0 | 6.0 | 14.3 | 22.8 | 31.5 | 21.7 | 100.0% | 101,501 |
Myeloma | 0.0 | 0.1 | 0.9 | 5.4 | 16.2 | 26.8 | 32.4 | 18.3 | 100.0% | 56,745 |
Leukemia: | 2.3 | 2.7 | 2.6 | 5.9 | 13.0 | 22.4 | 30.2 | 20.8 | 100.0% | 115,413 |
Lymphocytic: | 3.5 | 3.4 | 2.2 | 4.6 | 11.4 | 19.8 | 28.9 | 26.1 | 100.0% | 32,035 |
Acute lymphocytic | 15.6 | 14.8 | 8.5 | 11.2 | 14.3 | 15.7 | 12.8 | 7.1 | 100.0% | 7,124 |
Chronic lymphocytic | 0.0 | 0.1 | 0.4 | 2.6 | 10.5 | 21.1 | 33.7 | 31.8 | 100.0% | 22,906 |
Other lymphocytic | 1.3 | 1.4 | 1.1 | 4.9 | 11.3 | 19.7 | 31.6 | 28.7 | 100.0% | 2,005 |
Myeloid & Monocytic: | 1.8 | 2.7 | 3.2 | 7.1 | 14.9 | 24.9 | 30.1 | 15.3 | 100.0% | 56,401 |
Acute myeloid | 2.0 | 2.8 | 3.2 | 7.2 | 15.5 | 25.7 | 29.9 | 13.7 | 100.0% | 47,059 |
Chronic myeloid | 0.5 | 3.2 | 4.3 | 8.0 | 11.3 | 18.5 | 29.0 | 25.1 | 100.0% | 5,119 |
Acute monocytic | 2.5 | 1.0 | 1.7 | 6.4 | 11.8 | 25.1 | 31.1 | 20.5 | 100.0% | 483 |
Other myeloid & monocytic | 1.1 | 0.9 | 1.8 | 4.6 | 12.6 | 24.0 | 34.0 | 20.9 | 100.0% | 3,740 |
Other leukemia: | 2.0 | 2.1 | 2.0 | 4.8 | 10.9 | 20.4 | 32.0 | 25.9 | 100.0% | 26,977 |
Other acute leukemia | 1.3 | 2.2 | 2.0 | 4.5 | 11.0 | 21.2 | 33.0 | 25.0 | 100.0% | 9,429 |
Aleukemic, subleukemic & NOS | 2.3 | 2.0 | 2.0 | 4.9 | 10.8 | 20.0 | 31.5 | 26.4 | 100.0% | 17,548 |
Ill-defined & unspecified | 0.2 | 0.7 | 1.7 | 7.6 | 17.9 | 23.9 | 27.8 | 20.2 | 100.0% | 211,993 |
Footnotes:
Source: US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention. Percents may not sum to 100 due to rounding.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.